As noted in the inaugural President's message1 and seconded by Dr. Amsterdam,2 the recent alignment of the American Society for Preventive Cardiology (ASPC) and Preventive Cardiology provides an exceptional opportunity to enhance the mission of coronary heart disease (CHD) preventive efforts throughout North America. We hope to accomplish these tasks by bringing to the forefront a variety of strategies that include continuing medical education (CME), publication of supplements addressing timely issues, and advanced training in preventive cardiology (the latter will be addressed in future issues). CME remains an important mechanism for the dissemination of up-to-date information on a variety of topics in CHD prevention. While there are numerous outlets for conducting CME, teleconferencing has gained increasing popularity because of its value, convenience, and ease of administration. Among the most successful teleconferencing programs in recent years is the Women's Agenda Targeting Cholesterol in Heart Disease (WATCH)3 program developed to provide both summary and treatment recommendations based on the recent American Heart Association guidelines for women. WATCH is spearheaded by ASPC President-Elect Lori Mosca, and a number of ASPC members have participated as moderators of this interactive program. Based on the success of WATCH, ASPC is negotiating with other potential CME vendors. We will keep you informed of the progress made in securing educational teleconferencing venues, as ASPC members will play active roles in such CME programs. ASPC is also teaming up with Preventive Cardiology to develop supplements dedicated to timely issues in CHD prevention. Among the potential areas of interest are the following: The emerging role and importance of HDL cholesterol; Effect of omega-3 fatty acids in cardiovascular disease prevention; Update on triglyceride-rich lipoproteins and CHD risk; Obesity and the metabolic syndrome: therapeutic advances; Hypertension and hyperlipidemia: optimizing preventive strategies. Again, we will look to ASPC members interested in collaborating on these important and exciting activities. Another mission of ASPC during the upcoming year will be to enhance recruitment efforts. There are several groups focused on CHD prevention, but without ties to ASPC. One of these groups is the Emerging Science and Lipid Management (ESLM) group, cochaired by Drs. Tony Gotto and Peter Libby. Organized in 2001 to provide scientific and clinical updates in the field of atherothrombosis and CHD, members of the ESLM faculty are talented junior faculty and midlevel investigators dedicated to cardiovascular prevention. Another potentially rich source for ASPC membership recruitment is the membership of the National Lipid Association (NLA), a community of lipid professionals specializing in the management of dyslipidemia, currently presided over by Dr. John Guyton. NLA consists of chapters in the Southeast, Northeast, and Northwest representing more than 1000 physicians and allied health care personnel. Finally, two other groups whom we believe would be an asset to ASPC are members of the Vascular Biology Working Group (VBWG), headed by Dr. Carl Pepine, and the Coalition for the Advancement of Cardiovascular Health (COACH), led by Dr. Elijah Saunders. These groups are multidisciplinary in nature with members experienced in a wide range of CHD preventive approaches ranging from basic mechanisms in endothelial biology to clinical hypertension and the metabolic syndrome. We believe that attracting physicians and allied health care personnel from such diverse groups would add a new dimension to the Society without compromising its overall mission. As ASPC continues to flourish in upcoming years, we acknowledge the need for energetic and dedicated individuals willing to serve the Society in a leadership role. The Table lists the distinguished group of colleagues who have previously served in this capacity. Officers are generally elected to serve a 3-year term with annual promotions from Secretary- Treasurer to Vice Chair and then President. As I conclude my tenure, it has certainly been a great pleasure to have participated in this process. I wish to extend special thanks to Robin Crouse, Frank Franklin, and Norm Lasser for their guidance, helpful suggestions, and continued friendship during this period. I am equally delighted that Lori Mosca and Doug Schocken are the successors of ASPC leadership, because their energy and enthusiasm will both drive and strengthen the organization and its alliance with Preventive Cardiology.